BCV
KIN

Banque Cantonale Vaudoise’s Kindred Biosciences, Inc. KIN Stock Holding History

Banque Cantonale Vaudoise’s Portfolio KIN Stock Details KIN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,205
Closed -$10K – 1099
2020
Q2 		$10K Sell
2,205
-3,769
-63% -$16.8K ﹤0.01% 880
2020
Q1 		$24K Sell
5,974
-5,201
-47% -$44.2K ﹤0.01% 871
2019
Q4 		$95K Buy
+11,175
New +$87.2K 0.01% 815

Other funds holding KIN

PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Banque Cantonale Vaudoise's KIN Position: Q3 2020 in Review

Banque Cantonale Vaudoise sold out of Kindred Biosciences, Inc. (KIN) in Q3 2020, closing a stake of 2,205 shares — an estimated $10K sold.

Banque Cantonale Vaudoise first reported a position in KIN in Q4 2019 and held it in 3 quarters. The position peaked at $95K in Q4 2019. 77 funds tracked by Wall St. Rank hold KIN as of Q3 2020.

  • Banque Cantonale Vaudoise reported no remaining Kindred Biosciences, Inc. position as of Q3 2020 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 2,205 Kindred Biosciences, Inc. shares in Q3 2020, an estimated $10K.
  • Banque Cantonale Vaudoise first reported a position in Kindred Biosciences, Inc. in Q4 2019 and held it in 3 quarters.
  • Banque Cantonale Vaudoise's Kindred Biosciences, Inc. position peaked at $95K in Q4 2019.
  • 77 funds tracked by Wall St. Rank held Kindred Biosciences, Inc. as of Q3 2020.

Based on Banque Cantonale Vaudoise's 13F filing for Q3 2020, filed 30 Oct 2020.